Biotech · Private company
Tyme, Inc
Track this companyFree. Adds Tyme, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Capecitabine, Gemcitabine, and 5-FUPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- SM-88 used with MPS (methoxsalen, phenytoin, sirolimus)Phase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- SM88 (Cohort 1)Phase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- SM88 (Cohort 2)Phase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Oral SM-88 in Patients With Metastatic HR+/HER2- Breast CancerPHASE2 · TERMINATED · started Sep 22, 2021ClinicalTrials.gov NCT04720664 · fetched Nov 12, 2026
- SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for SarcomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 3, 2020ClinicalTrials.gov NCT03778996 · fetched Nov 12, 2026
- A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic CancerPHASE2_PHASE3 · TERMINATED · started Mar 27, 2018ClinicalTrials.gov NCT03512756 · fetched Nov 12, 2026
- Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate CancerPHASE1_PHASE2 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02796898 · fetched Nov 12, 2026